William S. Dalton
William S. Dalton is the chair of the IHMC Board of Directors. He is also Founder and CEO of M2GenĀ®, a national biotechnology subsidiary of Moffitt Cancer Center. Dr. Dalton received his Ph.D. in toxicology and medical life sciences and his M.D. degree from Indiana University. He is interested in developing approaches to enhance access to health care and developing evidence-based methods of evaluating and integrating new technologies into the standard of care.
Latest News
- STEM-Talk: Dr. Vyvyane Loh on atherosclerotic heart disease
- STEM-Talk: Dr. John Edwards on ketamine treatment for depression and suicide prevention
- Register now for IHMC Summer Robotics Camp 2024 sessions
- Peek behind the curtain at IHMC’s April 2024 Open House
- STEM-Talk: Dr. Michael Leon on the power of olfaction enrichment to ameliorate dementia symptoms
- IHMC hosts Dynamic Walking Conference in May 2024 drawing robotics experts from across the world
- Dr. Tom Jones Evening Lecture on March 14 includes book signing by Bodacious Bookstore
- STEM-Talk: Mark Mattson on the brain’s most important neurotransmitter
- IHMC Newsletter highlights human-machine teaming research and more